Balance Sheet
Cash Flow Statement
Gains from Sales and Divestitures
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Gains from Sales and Divestitures: 2014-2024

Historic Gains from Sales and Divestitures for Mesoblast (MESO) over the last 10 years, with Jun 2024 value amounting to $1,141.8 billion.

  • Mesoblast's Gains from Sales and Divestitures rose 13.66% to $1,154.0 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1,154.0 billion, marking a year-over-year increase of 13.66%. This contributed to the annual value of $1,141.8 billion for FY2024, which is 40.23% up from last year.
  • As of FY2024, Mesoblast's Gains from Sales and Divestitures stood at $1,141.8 billion, which was up 40.23% from $814.2 billion recorded in FY2023.
  • In the past 5 years, Mesoblast's Gains from Sales and Divestitures ranged from a high of $1,141.8 billion in FY2024 and a low of $583.9 billion during FY2020.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $814.2 billion (2023), whereas its average is $868.8 billion.
  • Data for Mesoblast's Gains from Sales and Divestitures shows a peak YoY soared of 40.23% (in 2024) over the last 5 years.
  • Over the past 5 years, Mesoblast's Gains from Sales and Divestitures (Yearly) stood at $583.9 billion in 2020, then increased by 11.09% to $648.7 billion in 2021, then increased by 0.27% to $650.5 billion in 2022, then grew by 25.17% to $814.2 billion in 2023, then spiked by 40.23% to $1,141.8 billion in 2024.